Cancer Cachexia Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
恶病质或消耗综合症是一种由于严重的慢性疾病而导致的极度体重减轻和肌肉萎缩、疲劳、虚弱和食欲不振的病症。患有癌症、艾滋病、多发性硬化症、肺结核、克罗恩病等慢性疾病的人会出现恶病质。由于宿主与肿瘤之间复杂的相互作用,癌症恶病质的致病性是多因素的。大多数患者因饥饿体重减轻、身体能量消耗过多和贫血而患有癌症恶病质。
市场动态
癌症恶病质市场预计将在由于恶病质患病率增加和用于治疗癌症恶病质的管道产品数量增加等驱动因素,该药物呈指数级增长。然而,人们对恶病质癌症缺乏认识,而且 FDA 批准程序漫长预计将阻碍市场增长。
市场范围
“全球癌症恶病质市场” 《2028 年分析》是一项专门且深入的研究,特别关注全球市场趋势分析。该报告旨在概述癌症恶病质市场,并按治疗方法、作用机制、分销渠道和地理位置进行详细的市场细分。预计全球癌症恶病质市场在预测期内将出现高速增长。该报告提供了主要癌症恶病质市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。
市场细分
全球癌症恶病质市场根据治疗方法、作用机制和分销渠道进行细分。根据治疗方法,市场分为孕激素、皮质类固醇、联合疗法等。根据作用机制,癌症恶病质市场分为食欲刺激剂、减肥稳定剂等。根据分销渠道,市场分为医院商店、零售药店和在线药房。
Cancer Cachexia Market: Strategic Insights
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Ãterna Zentaris Inc.
- ALDER BIOPHARMACEUTICALS, INC
- Aphios
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GTx, Inc.
- Helsinn Healthcare SA.
- Merck Sharp & Dohme Corp. (Merck & Co., Inc)
- Novartis AG
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美
- 欧洲
- 亚太地区
- 南美洲和中美洲
- 中东和非洲
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- 孕激素
- 皮质类固醇
- 联合疗法
- 其他
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 食欲刺激剂
- 减肥稳定剂
- 其他
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- 医院商店
- 零售药店
- 网上药房
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 北美
- 欧洲
- 亚太地区
- 南美洲和中美洲
该报告提供了该行业的详细概述包括定性和定量信息。它根据各个细分市场提供了全球癌症恶病质市场的概述和预测。它还提供了 2020 年至 2028 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美和非洲中美洲。每个地区的癌症恶病质市场随后按各自的国家和细分市场进行细分。报告涵盖了全球18个国家的分析和预测,以及该地区当前的趋势和机遇。
报告从需求和供给两个方面分析了影响癌症恶病质市场的因素,并进一步评估了影响癌症恶病质市场的市场动态。预测期内的市场,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:北美、欧洲、亚太地区、中东和非洲以及南美洲和南美洲中美洲在评估影响这些地区癌症恶病质市场的政治、经济、社会和技术因素后。
市场参与者
报告涵盖了癌症恶病质市场的主要发展,即有机和无机增长策略。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上见证的无机增长战略活动包括收购、合作和合作。合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对癌症恶病质的需求不断增长,预计癌症恶病质市场的市场参与者在未来将获得利润丰厚的增长机会。下面提到的是几家从事癌症恶病质市场的公司名单。
该报告还包括主要癌症恶病质市场公司的概况及其 SWOT 分析和市场策略。此外,该报告还重点关注领先的行业参与者,提供公司简介、提供的组件和服务、过去 3 年的财务信息、过去 5 年的主要发展等信息。
- Æterna Zentaris Inc.
- ALDER BIOPHARMACEUTICALS, INC
- Aphios
- 百时美施贵宝公司
- 礼来公司
- GTx, Inc.
- Helsinn Healthcare SA。
- Merck Sharp & Inc.。 Dohme Corp. (Merck & Co., Inc)
- Novartis AG
- XBiotech, Inc.
Cancer Cachexia Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ XX million |
Market Size by | US$ XX Million |
Global CAGR | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By 治疗
|
Regions and Countries Covered |
北美
|
Market leaders and key company profiles |
|
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
1. Æterna Zentaris Inc.
2. ALDER BIOPHARMACEUTICALS, INC
3. Aphios
4. Bristol-Myers Squibb Company
5. Eli Lilly and Company
6. GTx, Inc.
7. Helsinn Healthcare SA.
8. Merck Sharp & Dohme Corp. (Merck & Co., Inc)
9. Novartis AG
10. XBiotech, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.